Literature DB >> 3678956

Prognosis of chronic ulcerative colitis in a community.

C M Stonnington1, S F Phillips, A R Zinsmeister, L J Melton.   

Abstract

Utilising the population based data resources of the Rochester Epidemiology Project, we estimated survival and risk of subsequent colon cancer in the 182 residents of Rochester, Minnesota, initially diagnosed with chronic ulcerative colitis (CUC) between 1985 and 1979. Twenty five (13.7%) had a proctocolectomy during the course of follow up. Three patients developed colorectal adenocarcinoma after the initial diagnosis of CUC (relative risk = 1.9, 95% CI 0.4-5.4). Excluding proctitis cases, the relative risk of cancer was 2.4 (95% CI 0.3-8.7). At last follow up, 37 (20.3%) were dead; only 10 patients had chronic ulcerative colitis mentioned on the death certificate. Overall survival was similar to that expected for the general population of like age and sex. Our results suggest that chronic ulcerative colitis in the community is typically a milder disease than would appear from hospital or referral centre series.

Entities:  

Mesh:

Year:  1987        PMID: 3678956      PMCID: PMC1433453          DOI: 10.1136/gut.28.10.1261

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  19 in total

1.  A study of ulcerative colitis in New Zealand, showing a low incidence in Maoris.

Authors:  R D WIGLEY; B P MACLAURIN
Journal:  Br Med J       Date:  1962-07-28

2.  The development of carcinoma of the large intestine in ulcerative colitis.

Authors:  I M DAWSON; J PRYSE-DAVIES
Journal:  Br J Surg       Date:  1959-09       Impact factor: 6.939

3.  Ulcerative colitis in the Jewish population of Tel-Aviv Uafo. II: The rarity of malignant degeneration.

Authors:  T Gilat; Z Zemishlany; J Ribak; Y Bennaroya; P Lilos
Journal:  Gastroenterology       Date:  1974-11       Impact factor: 22.682

4.  An experience of ulcerative colitis. 3. Long term outcome.

Authors:  K N Jalan; R J Prescott; W Sircus; W I Card; J P McManus; C W Falconer; W P Small; A N Smith; J Bruce
Journal:  Gastroenterology       Date:  1970-10       Impact factor: 22.682

5.  Incidence of inflammatory bowel disease: going up or down?

Authors:  T Gilat
Journal:  Gastroenterology       Date:  1983-07       Impact factor: 22.682

6.  The patient record in epidemiology.

Authors:  L T Kurland; C A Molgaard
Journal:  Sci Am       Date:  1981-10       Impact factor: 2.142

7.  Cancer risk in ulcerative colitis: scientific requirements for the study of prognosis.

Authors:  D L Sackett; G Whelan
Journal:  Gastroenterology       Date:  1980-06       Impact factor: 22.682

8.  Nonspecific proctocolitis in northeastern Scotland: a community study.

Authors:  T S Sinclair; P W Brunt; N A Mowat
Journal:  Gastroenterology       Date:  1983-07       Impact factor: 22.682

9.  Mortality in ulcerative colitis.

Authors:  S Gyde; P Prior; M J Dew; V Saunders; J A Waterhouse; R N Allan
Journal:  Gastroenterology       Date:  1982-07       Impact factor: 22.682

10.  A comparison of cancer risk in Crohn's disease and ulcerative colitis.

Authors:  A J Greenstein; D B Sachar; H Smith; H D Janowitz; A H Aufses
Journal:  Cancer       Date:  1981-12-15       Impact factor: 6.860

View more
  13 in total

1.  Prognostic indicators and clinical course in proctosigmoiditis.

Authors:  L D Juby; D E Long; M F Dixon; A T Axon
Journal:  Int J Colorectal Dis       Date:  1990-12       Impact factor: 2.571

2.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

3.  Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival.

Authors:  E V Loftus; M D Silverstein; W J Sandborn; W J Tremaine; W S Harmsen; A R Zinsmeister
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

4.  Is inflammatory bowel disease an important risk factor among older persons with colorectal cancer in the United States? A population-based case-control study.

Authors:  Aasma Shaukat; Daniel J Virnig; Nadim I Salfiti; David H Howard; Shanthi V Sitaraman; Jonathan M Liff
Journal:  Dig Dis Sci       Date:  2011-03-16       Impact factor: 3.199

5.  Risk of colorectal cancer in self-reported inflammatory bowel disease and modification of risk by statin and NSAID use.

Authors:  N Jewel Samadder; Bhramar Mukherjee; Shu-Chen Huang; Jaeil Ahn; Hedy S Rennert; Joel K Greenson; Gad Rennert; Stephen B Gruber
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

6.  Colorectal cancer risk in Crohn's disease.

Authors:  Hugh-James Freeman
Journal:  World J Gastroenterol       Date:  2008-03-28       Impact factor: 5.742

7.  Correlation of serum-soluble triggering receptor expressed on myeloid cells-1 with clinical disease activity in inflammatory bowel disease.

Authors:  Jae Jun Park; Jae Hee Cheon; Bo Young Kim; Duk Hwan Kim; Eun Soo Kim; Tae Il Kim; Kyoung Ryul Lee; Won Ho Kim
Journal:  Dig Dis Sci       Date:  2008-10-31       Impact factor: 3.199

8.  Divergent patterns of total and cancer mortality in ulcerative colitis and Crohn's disease patients: the Florence IBD study 1978-2001.

Authors:  G Masala; S Bagnoli; M Ceroti; C Saieva; G Trallori; I Zanna; G D'Albasio; D Palli
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

9.  Incidence of colorectal cancer and all cause mortality in non-selected patients with ulcerative colitis and indeterminate colitis in Malmö, Sweden.

Authors:  J Stewénius; I Adnerhill; H Anderson; G R Ekelund; C H Florén; F T Fork; L Janzon; C Lindström; M Ogren
Journal:  Int J Colorectal Dis       Date:  1995       Impact factor: 2.571

10.  Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients.

Authors:  R G Farmer; K A Easley; G B Rankin
Journal:  Dig Dis Sci       Date:  1993-06       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.